RESUMO
Menopausal women are at high risk for osteoporosis than adult women. This study was carried on 60 postmenopausal women with age ranged 45-65 years old, and the last menses was at least one year before. Bone densimetry was performed for every case to confirm the diagnosis. These cases were classified into four groups: group I [control]: 20 postmenopausal women without osteoporosis and not on treatment. Group II: 20 osteoporotic postmenopausal women and not on treatment. Group III 10 osteoporotic postmenopausal women and on hormone replacement therapy [HRT]. Group IV: 10 osteoporotic postmenopausal women and on vitamin D, calcium and exercise therapy. Lines of treatment include hormonal replacement therapy, calcium supplements, vitamin D, fluoride therapy, calcitonin and diphosphonates. In this study, the most two common lines of treatment [HRT and calcium, vitamin D and exercise] were used and results compared. The urinary deoxypyridinoline links as a marker for bone degradation showed improvement by both lines of therapy. It was significantly decreased when compared to osteoporotic women on no treatment. It is advisable to use calcium supplements, vitamin D and exercise to avoid the hazards of HRT which may include venous thrombosis, fibromyomas and other complications. The success of calcium, vitamin D and exercise to improve osteoporosis make this line of treatment advisable to be used in women as well as in men who suffer from osteoporosis to avoid any hazards of anabolic steroids